Analysis of methylated nucleic acid

Details for Australian Patent Application No. 2005254616 (hide)

Owner Novartis Forschungsstiftung, Zweigniederlassung Friedrich Miescher Institute for Biomedical Research

Inventors Weber, Michael Philippe; Schuebeler, Dirk

Agent Davies Collison Cave

Pub. Number AU-A-2005254616

PCT Pub. Number WO2005/123942

Priority 0413688.3 18.06.04 GB

Filing date 3 March 2005

Wipo publication date 29 December 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C12N 15/10 (2006.01) Mutation or genetic engineering - Processes for the isolation, preparation or purification of DNA or RNA

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123942 Priority application(s): WO2005/123942

30 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254617-3-aminoindazoles

2005254613-FGFR binding peptides